Effectiveness of Radiofrequency Assisted Inferior Turbinoplasty in Symptomatic Patients with Inferior Turbinate Hypertrophy

Assessment of the Effectiveness of Radiofrequency Assisted Inferior Turbinoplasty in Patients with Symptomatic Inferior Turbinate Hypertrophy - NIL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/062221

Enrollment

Registered

2024-02-01

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: radiofrequency assisted inferior turbinate hypertrophy: patients with inferior turbinate hypertrophy, refractory to medical treatment for more than 3 months will undergo radiofrequency

Eligibility

Inclusion criteria

Inclusion criteria: patients with chronic hypertrophy of inferior turbinate, age group between 18 to 60 years hypertrophy of inferior turbinate in symptomatic patients patients not responding to medical treatment for inferior turbinate hypertrophy within a period of 3 months

Exclusion criteria

Exclusion criteria: patient with asymptomatic hypertrophy of inferior turbinate patients who have already undergone any nasal surgery patients with bleeding diathesis, acute respiratory tract infections, malignancy of nose and paranasal sinuses and other uncontrolled co morbidities

Design outcomes

Primary

Measure	Time frame
to assess the surgical outcome of radiofrequency assisted inferior turbinoplastyTimepoint: post surgery- 2 weeks, 1 month, 3months	—

Secondary

Measure	Time frame
to analyse the pre operative and post operative symptomatology score using SNOT questionnaire and endoscopic scoring systemTimepoint: post surgery- 2 weeks, 1 month, 3 months	—

Countries

India

Contacts

Public ContactKARTHIKEYAN P

Mahatma Gandhi Medical College and Research Institute

karthikent73@gmail.com9443381302

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026